Global Human Rabies Immunoglobulin IM Market Research Report 2023(Status and Outlook)

Global Human Rabies Immunoglobulin IM Market Research Report 2023(Status and Outlook)



Report Overview

Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.

Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization.

In this report, we study ERIG (Equine Rabies Immunoglobulin) and HRIG (Human Rabies Immunoglobulin)

Global Human Rabies Immunoglobulin (IM) key players include CSL Behring, Grifols, Sanofi, etc. Global top three manufacturers hold a share about 60%.

North America is the largest market, with a share over 30%, followed by China and Europe, both have a share about 45 percent.

In terms of product, HRIG is the largest segment, with a share over 85%. And in terms of application, the largest application is Category III Exposure, followed by Category II Exposure.

The Global Human Rabies Immunoglobulin IM Market Size was estimated at USD 362.00 million in 2022 and is projected to reach USD 551.54 million by 2029, exhibiting a CAGR of 6.20% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Human Rabies Immunoglobulin IM market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Rabies Immunoglobulin IM Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Rabies Immunoglobulin IM market in any manner.

Global Human Rabies Immunoglobulin IM Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

CSL Behring

Grifols

Sanofi

Sichuan Yuanda Shuyang

CNBG

Kamada

CBPO

Shuanglin Bio

Weiguang Bio

Shanghai RAAS

Bharat Serum

VINS

Market Segmentation (by Type)

ERIG

HRIG

Market Segmentation (by Application)

Oil and Gas

Chemical Industry

Water and Waste Water Treatment

Pharmaceuticals

Food and Beverage

Paper/Packaging

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Human Rabies Immunoglobulin IM Market

Overview of the regional outlook of the Human Rabies Immunoglobulin IM Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Human Rabies Immunoglobulin IM
1.2 Key Market Segments
1.2.1 Human Rabies Immunoglobulin IM Segment by Type
1.2.2 Human Rabies Immunoglobulin IM Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Human Rabies Immunoglobulin IM Market Overview
2.1 Global Market Overview
2.1.1 Global Human Rabies Immunoglobulin IM Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Human Rabies Immunoglobulin IM Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Human Rabies Immunoglobulin IM Market Competitive Landscape
3.1 Global Human Rabies Immunoglobulin IM Sales by Manufacturers (2018-2023)
3.2 Global Human Rabies Immunoglobulin IM Revenue Market Share by Manufacturers (2018-2023)
3.3 Human Rabies Immunoglobulin IM Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Rabies Immunoglobulin IM Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Human Rabies Immunoglobulin IM Sales Sites, Area Served, Product Type
3.6 Human Rabies Immunoglobulin IM Market Competitive Situation and Trends
3.6.1 Human Rabies Immunoglobulin IM Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Rabies Immunoglobulin IM Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Human Rabies Immunoglobulin IM Industry Chain Analysis
4.1 Human Rabies Immunoglobulin IM Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Human Rabies Immunoglobulin IM Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Human Rabies Immunoglobulin IM Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Rabies Immunoglobulin IM Sales Market Share by Type (2018-2023)
6.3 Global Human Rabies Immunoglobulin IM Market Size Market Share by Type (2018-2023)
6.4 Global Human Rabies Immunoglobulin IM Price by Type (2018-2023)
7 Human Rabies Immunoglobulin IM Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Rabies Immunoglobulin IM Market Sales by Application (2018-2023)
7.3 Global Human Rabies Immunoglobulin IM Market Size (M USD) by Application (2018-2023)
7.4 Global Human Rabies Immunoglobulin IM Sales Growth Rate by Application (2018-2023)
8 Human Rabies Immunoglobulin IM Market Segmentation by Region
8.1 Global Human Rabies Immunoglobulin IM Sales by Region
8.1.1 Global Human Rabies Immunoglobulin IM Sales by Region
8.1.2 Global Human Rabies Immunoglobulin IM Sales Market Share by Region
8.2 North America
8.2.1 North America Human Rabies Immunoglobulin IM Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Rabies Immunoglobulin IM Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Rabies Immunoglobulin IM Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Rabies Immunoglobulin IM Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Rabies Immunoglobulin IM Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 CSL Behring
9.1.1 CSL Behring Human Rabies Immunoglobulin IM Basic Information
9.1.2 CSL Behring Human Rabies Immunoglobulin IM Product Overview
9.1.3 CSL Behring Human Rabies Immunoglobulin IM Product Market Performance
9.1.4 CSL Behring Business Overview
9.1.5 CSL Behring Human Rabies Immunoglobulin IM SWOT Analysis
9.1.6 CSL Behring Recent Developments
9.2 Grifols
9.2.1 Grifols Human Rabies Immunoglobulin IM Basic Information
9.2.2 Grifols Human Rabies Immunoglobulin IM Product Overview
9.2.3 Grifols Human Rabies Immunoglobulin IM Product Market Performance
9.2.4 Grifols Business Overview
9.2.5 Grifols Human Rabies Immunoglobulin IM SWOT Analysis
9.2.6 Grifols Recent Developments
9.3 Sanofi
9.3.1 Sanofi Human Rabies Immunoglobulin IM Basic Information
9.3.2 Sanofi Human Rabies Immunoglobulin IM Product Overview
9.3.3 Sanofi Human Rabies Immunoglobulin IM Product Market Performance
9.3.4 Sanofi Business Overview
9.3.5 Sanofi Human Rabies Immunoglobulin IM SWOT Analysis
9.3.6 Sanofi Recent Developments
9.4 Sichuan Yuanda Shuyang
9.4.1 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin IM Basic Information
9.4.2 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin IM Product Overview
9.4.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin IM Product Market Performance
9.4.4 Sichuan Yuanda Shuyang Business Overview
9.4.5 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin IM SWOT Analysis
9.4.6 Sichuan Yuanda Shuyang Recent Developments
9.5 CNBG
9.5.1 CNBG Human Rabies Immunoglobulin IM Basic Information
9.5.2 CNBG Human Rabies Immunoglobulin IM Product Overview
9.5.3 CNBG Human Rabies Immunoglobulin IM Product Market Performance
9.5.4 CNBG Business Overview
9.5.5 CNBG Human Rabies Immunoglobulin IM SWOT Analysis
9.5.6 CNBG Recent Developments
9.6 Kamada
9.6.1 Kamada Human Rabies Immunoglobulin IM Basic Information
9.6.2 Kamada Human Rabies Immunoglobulin IM Product Overview
9.6.3 Kamada Human Rabies Immunoglobulin IM Product Market Performance
9.6.4 Kamada Business Overview
9.6.5 Kamada Recent Developments
9.7 CBPO
9.7.1 CBPO Human Rabies Immunoglobulin IM Basic Information
9.7.2 CBPO Human Rabies Immunoglobulin IM Product Overview
9.7.3 CBPO Human Rabies Immunoglobulin IM Product Market Performance
9.7.4 CBPO Business Overview
9.7.5 CBPO Recent Developments
9.8 Shuanglin Bio
9.8.1 Shuanglin Bio Human Rabies Immunoglobulin IM Basic Information
9.8.2 Shuanglin Bio Human Rabies Immunoglobulin IM Product Overview
9.8.3 Shuanglin Bio Human Rabies Immunoglobulin IM Product Market Performance
9.8.4 Shuanglin Bio Business Overview
9.8.5 Shuanglin Bio Recent Developments
9.9 Weiguang Bio
9.9.1 Weiguang Bio Human Rabies Immunoglobulin IM Basic Information
9.9.2 Weiguang Bio Human Rabies Immunoglobulin IM Product Overview
9.9.3 Weiguang Bio Human Rabies Immunoglobulin IM Product Market Performance
9.9.4 Weiguang Bio Business Overview
9.9.5 Weiguang Bio Recent Developments
9.10 Shanghai RAAS
9.10.1 Shanghai RAAS Human Rabies Immunoglobulin IM Basic Information
9.10.2 Shanghai RAAS Human Rabies Immunoglobulin IM Product Overview
9.10.3 Shanghai RAAS Human Rabies Immunoglobulin IM Product Market Performance
9.10.4 Shanghai RAAS Business Overview
9.10.5 Shanghai RAAS Recent Developments
9.11 Bharat Serum
9.11.1 Bharat Serum Human Rabies Immunoglobulin IM Basic Information
9.11.2 Bharat Serum Human Rabies Immunoglobulin IM Product Overview
9.11.3 Bharat Serum Human Rabies Immunoglobulin IM Product Market Performance
9.11.4 Bharat Serum Business Overview
9.11.5 Bharat Serum Recent Developments
9.12 VINS
9.12.1 VINS Human Rabies Immunoglobulin IM Basic Information
9.12.2 VINS Human Rabies Immunoglobulin IM Product Overview
9.12.3 VINS Human Rabies Immunoglobulin IM Product Market Performance
9.12.4 VINS Business Overview
9.12.5 VINS Recent Developments
10 Human Rabies Immunoglobulin IM Market Forecast by Region
10.1 Global Human Rabies Immunoglobulin IM Market Size Forecast
10.2 Global Human Rabies Immunoglobulin IM Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Human Rabies Immunoglobulin IM Market Size Forecast by Country
10.2.3 Asia Pacific Human Rabies Immunoglobulin IM Market Size Forecast by Region
10.2.4 South America Human Rabies Immunoglobulin IM Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Human Rabies Immunoglobulin IM by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Human Rabies Immunoglobulin IM Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Human Rabies Immunoglobulin IM by Type (2024-2029)
11.1.2 Global Human Rabies Immunoglobulin IM Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Human Rabies Immunoglobulin IM by Type (2024-2029)
11.2 Global Human Rabies Immunoglobulin IM Market Forecast by Application (2024-2029)
11.2.1 Global Human Rabies Immunoglobulin IM Sales (K MT) Forecast by Application
11.2.2 Global Human Rabies Immunoglobulin IM Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings